annual operating expenses:
$828.62M-$26.58M(-3.11%)Summary
- As of today (July 1, 2025), APLS annual total operating expenses is $828.62 million, with the most recent change of -$26.58 million (-3.11%) on December 31, 2024.
- During the last 3 years, APLS annual operating expenses has risen by +$230.98 million (+38.65%).
- APLS annual operating expenses is now -3.11% below its all-time high of $855.20 million, reached on December 31, 2023.
Performance
APLS Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$215.76M+$17.93M(+9.06%)Summary
- As of today (July 1, 2025), APLS quarterly total operating expenses is $215.76 million, with the most recent change of +$17.93 million (+9.06%) on March 31, 2025.
- Over the past year, APLS quarterly operating expenses has increased by +$1.56 million (+0.73%).
- APLS quarterly operating expenses is now -4.13% below its all-time high of $225.07 million, reached on September 30, 2023.
Performance
APLS quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
APLS Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.1% | +0.7% |
| 3 y3 years | +38.6% | +51.8% |
| 5 y5 years | +187.7% | +118.4% |
APLS Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.1% | +38.6% | -4.1% | +30.9% |
| 5 y | 5-year | -3.1% | +187.7% | -4.1% | +127.5% |
| alltime | all time | -3.1% | >+9999.0% | -4.1% | +7985.3% |
APLS Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $215.76M(+9.1%) |
| Dec 2024 | $828.62M(-3.1%) | $197.84M(-6.0%) |
| Sep 2024 | - | $210.55M(+2.2%) |
| Jun 2024 | - | $206.03M(-3.8%) |
| Mar 2024 | - | $214.21M(+1.5%) |
| Dec 2023 | $855.20M(+28.7%) | $210.98M(-6.3%) |
| Sep 2023 | - | $225.07M(+8.7%) |
| Jun 2023 | - | $207.03M(-2.4%) |
| Mar 2023 | - | $212.12M(+15.4%) |
| Dec 2022 | $664.40M(+11.2%) | $183.79M(+5.9%) |
| Sep 2022 | - | $173.61M(+5.3%) |
| Jun 2022 | - | $164.86M(+16.0%) |
| Mar 2022 | - | $142.13M(-1.7%) |
| Dec 2021 | $597.64M(+36.0%) | $144.64M(+8.4%) |
| Sep 2021 | - | $133.50M(-31.5%) |
| Jun 2021 | - | $194.91M(+56.4%) |
| Mar 2021 | - | $124.59M(+31.4%) |
| Dec 2020 | $439.32M | $94.83M(-27.2%) |
| Sep 2020 | - | $130.20M(+12.7%) |
| Jun 2020 | - | $115.51M(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $98.79M(-6.8%) |
| Dec 2019 | $288.01M(+125.1%) | $105.94M(+51.5%) |
| Sep 2019 | - | $69.95M(+10.2%) |
| Jun 2019 | - | $63.48M(+30.5%) |
| Mar 2019 | - | $48.65M(+30.8%) |
| Dec 2018 | $127.92M(+152.0%) | $37.20M(+3.9%) |
| Sep 2018 | - | $35.80M(+6.9%) |
| Jun 2018 | - | $33.49M(+56.2%) |
| Mar 2018 | - | $21.44M(+19.1%) |
| Dec 2017 | $50.77M(+86.1%) | $17.99M(+55.3%) |
| Sep 2017 | - | $11.59M(-4.5%) |
| Jun 2017 | - | $12.13M(+34.0%) |
| Mar 2017 | - | $9.05M(+35.5%) |
| Dec 2016 | $27.28M(+35.8%) | $6.68M(-7.7%) |
| Sep 2016 | - | $7.23M(+3.9%) |
| Dec 2015 | $20.09M(+77.9%) | $6.96M(+35.0%) |
| Sep 2015 | - | $5.16M(+76.9%) |
| Dec 2014 | $11.29M(+180.3%) | $2.92M(+9.3%) |
| Sep 2014 | - | $2.67M |
| Dec 2013 | $4.03M | - |
FAQ
- What is Apellis Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual operating expenses year-on-year change?
- What is Apellis Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly operating expenses year-on-year change?
What is Apellis Pharmaceuticals annual total operating expenses?
The current annual operating expenses of APLS is $828.62M
What is the all time high annual operating expenses for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total operating expenses is $855.20M
What is Apellis Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, APLS annual total operating expenses has changed by -$26.58M (-3.11%)
What is Apellis Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of APLS is $215.76M
What is the all time high quarterly operating expenses for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total operating expenses is $225.07M
What is Apellis Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, APLS quarterly total operating expenses has changed by +$1.56M (+0.73%)